Bio-Path Holdings Inc (BPTH)
1.88
-0.15
(-7.39%)
USD |
NASDAQ |
May 28, 16:00
1.88
0.00 (0.00%)
After-Hours: 20:00
Bio-Path Holdings Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2021 | 20.01M |
| September 30, 2021 | 24.30M |
| June 30, 2021 | 22.90M |
| March 31, 2021 | 22.90M |
| December 31, 2020 | 4.289M |
| September 30, 2020 | 7.289M |
| June 30, 2020 | 7.458M |
| March 31, 2020 | 7.503M |
| December 31, 2019 | 27.78M |
| September 30, 2019 | 20.50M |
| June 30, 2019 | 21.50M |
| March 31, 2019 | 21.46M |
| December 31, 2018 | 1.18M |
| September 30, 2018 | 4.746M |
| June 30, 2018 | 3.537M |
| March 31, 2018 | 5.085M |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 |
| Date | Value |
|---|---|
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 14.25M |
| September 30, 2014 | 13.74M |
| June 30, 2014 | 16.63M |
| March 31, 2014 | 18.84M |
| December 31, 2013 | 5.331M |
| September 30, 2013 | 6.030M |
| June 30, 2013 | 3.852M |
| March 31, 2013 | 1.856M |
| December 31, 2012 | 1.600M |
| September 30, 2012 | 1.473M |
| June 30, 2012 | 0.9021M |
| March 31, 2012 | 1.399M |
| December 31, 2011 | 2.034M |
| September 30, 2011 | 1.873M |
| June 30, 2011 | 1.903M |
| March 31, 2011 | 1.535M |
| December 31, 2010 | 1.049M |
| September 30, 2010 | 1.309M |
| June 30, 2010 | 1.138M |
| March 31, 2010 | 0.9405M |
| December 31, 2009 | 0.7376M |
| September 30, 2009 | 0.1187M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
4.289M
Minimum
Dec 2020
27.78M
Maximum
Dec 2019
16.95M
Average
20.50M
Median
Sep 2019
Cash from Financing (TTM) Benchmarks
| INVO Bioscience Inc | 4.665M |
| Perspective Therapeutics Inc | 167.19M |
| EyePoint Pharmaceuticals Inc | 192.30M |
| Palatin Technologies Inc | 14.71M |
| Lumos Pharma Inc | -0.272M |